Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 3Liver Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Lung Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Gallbladder Neoplasms 1Fibrosarcoma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Bile Duct Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 11Vincristine 9Temozolomide 7Magnetic Resonance Spectroscopy 6Irinotecan 6Filgrastim 6Etoposide 6Doxorubicin 6X-Rays 5Phantoms, Imaging 5Ifosfamide 5Dactinomycin 5cixutumumab 4Vinorelbine 4Specimen Handling 4Sirolimus 4Nuclear Medicine Department, Hospital 4Melphalan 4Gemcitabine 4pegfilgrastim 3palbociclib 3Tacrolimus 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Dexrazoxane 3Biopsy 3ulixertinib 2tipifarnib 2thymoglobulin 2temsirolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rhabdomyosarcoma × exatecan × Clear all
NCT00041236 2012-07-18

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
39 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡